# SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid90158903
Categories: food, industrial, pharma
Identifier: DTXSID90158903

> SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE. EPA CPDat observed this chemical in 4 composition records across product categories including Food and drug, Laboratory supplies. Compiled from 7 published data sources.

## Safety assessment

- Chemical concern: not yet assessed
- Is it a concern? We haven't assessed a concern score for this ingredient yet.
- Rationale: EPA CPDat observed this chemical in 4 composition records across product categories including Food and drug, Laboratory supplies.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 4 composition records across product categories including Food and drug, Laboratory supplies.
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 12.8 mg
- US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION, SOLUTION; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 12.8 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 1.6 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 115 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1.15 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 63 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 140 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 0.3 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 1.3 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.3 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Potency: 0.02 %w/w
- US: marketed drug occurrence — FDA NDC lists this ingredient in 3 active drug products and 3 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

## Expert safety opinions

- JECFA (Joint FAO/WHO Expert Committee on Food Additives): no opinion on file.
- EFSA (European Food Safety Authority): no opinion on file.

## Data sources

- EPA Chemical and Products Database (updated 2019-02-27): http://siri.org/msds/f2/brz/brzdd.html
- EPA DSSTox Identifiers (updated 2025-12-29): https://epa.figshare.com/articles/dataset/Chemistry_Dashboard_Data_DSSTox_Identifiers_Mapped_to_CAS_Numbers_and_Names/5588566
- FDA Inactive Ingredient Database (updated 2026-01-09): https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-database-download
- FDA National Drug Code Directory (updated 2026-12-31): https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory-support-files
- FDA GSRS UNII (updated 2026-02-26): https://precision.fda.gov/uniisearch/
- openFDA Substance (updated 2026-05-24): https://api.fda.gov/other/substance.json?search=unii:5QWK665956
- PubChem Live Enrichment (updated 2026-05-17): https://pubchem.ncbi.nlm.nih.gov/compound/23673460

_Assessed by Greenveil._